Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
PrematurityVascular Aging
Interventions
DIETARY_SUPPLEMENT

Humavant

"Premature infants are randomized to either:~1. An exclusive human milk diet which contains mother's milk or pasteurized donor human milk and the human milk fortifier until 36 weeks of gestation; OR~2. Human milk (as long as available) and the human milk fortifier (as long as human milk is available) until a maximum of 32 weeks of gestation and thereafter human milk with a bovine-based fortifier or preterm formula.~After 36 weeks of gestation, human milk with a bovine-based fortifier or preterm formula is used in both groups. As a control group, term-born age-matched controls are included."

Trial Locations (1)

A-6020

RECRUITING

Medical University of Innsbruck, Innsbruck

All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

collaborator

Federal University Teaching Hospital, Feldkirch, Austria

OTHER

collaborator

Paracelsus Medical University

OTHER

lead

Prolacta Bioscience

INDUSTRY